RPR107393
RPR107393 is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 reduces plasma cholesterol in rats and marmosets. RPR107393 can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis[1][2].
Product Specifications
CAS Number
190841-57-7
UNSPSC
12352005
Target
Farnesyl Transferase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cardiovascular Disease; Metabolic Disease
Solubility
10 mM in DMSO
Smiles
OC1(C2=CC=C(C3=CC=C4N=CC=CC4=C3)C=C2)CN5CCC1CC5.Cl.Cl
Molecular Formula
C22H24Cl2N2O
Molecular Weight
403.34
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![SPARC Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1D6]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
SPARC Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1D6]
Pcdh20 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)